A Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients
Clinical trial NCT01730768 · COMPLETED
Trial details
- NCT number
- NCT01730768
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2013-12-01
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.